Literature DB >> 7543212

Gliadin-specific T cell responses in peripheral blood of healthy individuals involve T cells restricted by the coeliac disease associated DQ2 heterodimer.

K Jensen1, L M Sollid, H Scott, G Paulsen, K Kett, E Thorsby, K E Lundin.   

Abstract

Coeliac disease (CD) is probably caused by an abnormal immune response towards wheat gliadin in the small intestine. We found that gliadin-specific T cells from the small intestinal mucosa of HLA-DQ2 positive CD patients were almost exclusively restricted by the disease-associated DQ2 molecule. In the peripheral blood of CD patients, a large proportion of gliadin-specific T cells were found to be restricted by DQ molecules, including DQ2, but many were instead restricted by DR or DP molecules of the patient. We have now investigated gliadin-specific T cell responses in peripheral blood from healthy individuals. Four of 20 persons tested had strong in vitro responses and were used as donors for gliadin-specific T cell clones. We found gliadin-specific T cells restricted by the CD-associated DQ2 molecule in peripheral blood for two of these four individuals. It is the presence of such T cells also in the small intestinal mucosa which seems typical of CD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543212     DOI: 10.1111/j.1365-3083.1995.tb03640.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin.

Authors:  E H A Spaenij-Dekking; E M C Kooy-Winkelaar; W F Nieuwenhuizen; J W Drijfhout; F Koning
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten.

Authors:  A Camarca; G Radano; R Di Mase; G Terrone; F Maurano; S Auricchio; R Troncone; L Greco; C Gianfrani
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

3.  T cells in peripheral blood after gluten challenge in coeliac disease.

Authors:  R P Anderson; D A van Heel; J A Tye-Din; M Barnardo; M Salio; D P Jewell; A V S Hill
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

4.  T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC).

Authors:  J O'Keeffe; K Mills; J Jackson; C Feighery
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 5.  Vaccine against autoimmune disease: antigen-specific immunotherapy.

Authors:  Robert P Anderson; Bana Jabri
Journal:  Curr Opin Immunol       Date:  2013-03-13       Impact factor: 7.486

6.  Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype--implications for the role of transglutaminase in coeliac disease.

Authors:  William J Dalleywater; David Y S Chau; Amir M Ghaemmaghami
Journal:  BMC Immunol       Date:  2012-04-16       Impact factor: 3.615

7.  Intestinal permeability and antigliadin antibody test for monitoring adult patients with celiac disease.

Authors:  Eduardo Garcia Vilela; Maria de Lourdes de Abreu Ferrari; Henrique Osvaldo de Gama Torres; Fabiana Paiva Martins; Eugênio Marcos Andrade Goulart; Agnaldo Soares Lima; Aloíso Sales da Cunha
Journal:  Dig Dis Sci       Date:  2007-03-14       Impact factor: 3.487

Review 8.  Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications.

Authors:  Stefania Picascia; Roberta Mandile; Renata Auricchio; Riccardo Troncone; Carmen Gianfrani
Journal:  Nutrients       Date:  2015-12-02       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.